In contrast to adult patients where MYST (MOZ/Ybf2/Sas2/TIP60) fusions are often associated with therapy-related AML, in pediatric patients, these fusions are found in congenital and perinatal leukemia. The gene discussed is KAT6A; the disease is acute myeloid leukemia.